Could Exact Sciences Corp.’s (NASDAQ: EXAS) Earnings Exceed Your Expectations?

In today’s recent session, 0.63 million shares of the Exact Sciences Corp. (NASDAQ:EXAS) have been traded, and its beta is 1.23. Most recently the company’s share price was $40.97, and it changed around -$0.98 or -2.33% from the last close, which brings the market valuation of the company to $7.56B. EXAS at last check was trading at a discount to its 52-week high of $100.77, offering almost -145.96% off that amount. The share price’s 52-week low was $41.08, which indicates that the recent value has fallen by an impressive -0.27% since then. We note from Exact Sciences Corp.’s average daily trading volume that its 3-month average coming to 3.21 million.

Exact Sciences Corp. stock received a consensus recommendation rating of Hold, based on a mean score of 1.30. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 5 recommended EXAS as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Exact Sciences Corp. is expected to report earnings per share of -0.31 for the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Exact Sciences Corp. (NASDAQ:EXAS) trade information

Instantly EXAS has been showing red trend so far today with a performance of -2.33% on intraday trading today. The performance over the last five days has remained in the red territory. The company’s shares are currently down -44.61% year-to-date, but still down -0.86% over the last five days. On the other hand, Exact Sciences Corp. (NASDAQ:EXAS) is -24.23% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $96.29, which translates to bulls needing to increase their stock price by 57.45% from its current value. Analyst projections state that EXAS is forecast to be at a low of $40 and a high of $168.

Exact Sciences Corp. (EXAS) estimates and forecasts

Exact Sciences Corp. share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -42.64 percent over the past six months and at a -10.62% annual growth rate that is well below the industry average of 15.60%. The year-over-year growth rate is expected to be 13.20%, up from the previous year.

Consensus estimates provided by 21 financial analysts predict the company will bring in an average of 690.33M in revenue for the current quarter. 21 analysts expect Exact Sciences Corp. to make 730.15M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 622.09M and 616.81M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 11.00%. Forecasts for the next quarter put sales growth at 18.40%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 4.59%.

EXAS Dividends

Exact Sciences Corp.’s next quarterly earnings report is expected to be released in July.